These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 448162)

  • 1. Effect of dicarboxylic acids on lentigo maligna.
    Nazzaro-Porro M; Passi S; Balus L; Breathnach A; Martin B; Morpurgo G
    J Invest Dermatol; 1979 Jun; 72(6):296-305. PubMed ID: 448162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent progression of lentigo maligna to invasive melanoma during treatment with topical azelaic acid.
    McLean DI; Peter KK
    Br J Dermatol; 1986 Jun; 114(6):685-9. PubMed ID: 3718862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dicarboxylic acids on normal human melanocytes in dispersed tissue culture.
    Breathnach AS; Martin B; Nazzaro Porro M; Passi S; Mann P; Cooper J; Morpurgo G
    Br J Dermatol; 1979 Dec; 101(6):641-9. PubMed ID: 534609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten years' experience of treating lentigo maligna with topical azelaic acid.
    Nazzaro-Porro M; Passi S; Zina G; Breathnach AS
    Acta Derm Venereol Suppl (Stockh); 1989; 143():49-57. PubMed ID: 2773614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lentigo maligna with azelaic acid.
    Rodríguez Prieto MA; Manchado Lopez P; Ruiz Gonzalez I; Suarez D
    Int J Dermatol; 1993 May; 32(5):363-4. PubMed ID: 8505164
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent lentigo maligna melanoma: regression associated with local azelaic acid 20%.
    Vereecken P; Heenen M
    Int J Clin Pract; 2002; 56(1):68-9. PubMed ID: 11831841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azelaic acid in lentigo maligna.
    Br J Dermatol; 1987 Apr; 116(4):605-7. PubMed ID: 3580294
    [No Abstract]   [Full Text] [Related]  

  • 8. Azelaic acid.
    Nazzaro-Porro M
    J Am Acad Dermatol; 1987 Dec; 17(6):1033-41. PubMed ID: 2963038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-microscopic investigations of pigment cells of lentigo maligna (melanosis circumscripta praeblastomatosa Dubreuilh) and lentigo maligna melanoma.
    Paul E; Illig L
    Arch Dermatol Res (1975); 1976 Aug; 256(2):179-87. PubMed ID: 962389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA synthesis of melanoma cells by azelaic acid.
    Leibl H; Stingl G; Pehamberger H; Korschan H; Konrad K; Wolff K
    J Invest Dermatol; 1985 Nov; 85(5):417-22. PubMed ID: 4056455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Black lesions of the skin.
    BECKER SW
    Calif Med; 1958 Mar; 88(3):228-33. PubMed ID: 13511215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of azelaic acid on cultures of lymphoma- and leukemia-derived cell lines, normal resting and stimulated lymphocytes and 3T3 fibroblasts.
    Picardo M; Passi S; Sirianni MC; Fiorilli M; Russo GD; Cortesi E; Barile G; Breathnach AS; Nazzaro-Porro M
    Biochem Pharmacol; 1985 May; 34(10):1653-8. PubMed ID: 4004885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
    Pathak MA; Ciganek ER; Wick M; Sober AJ; Farinelli WA; Fitzpatrick TB
    J Invest Dermatol; 1985 Sep; 85(3):222-8. PubMed ID: 4031538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathology of lentigo maligna Hutchinson. Melanosis circumscripta praecancerosa Dubreuilh (author's transl)].
    Tilgen W; Schnyder UW
    Virchows Arch A Pathol Anat Histol; 1974; 363(2):163-74. PubMed ID: 4849938
    [No Abstract]   [Full Text] [Related]  

  • 15. A possible mechanism of action for azelaic acid in the human epidermis.
    Schallreuter KU; Wood JW
    Arch Dermatol Res; 1990; 282(3):168-71. PubMed ID: 2114832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
    Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
    Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subungual lentigo maligna.
    Clouse WE; Sanders LJ
    Cutis; 1985 Aug; 36(2):153-5. PubMed ID: 4028830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
    Flotte TJ; Mihm MC
    Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dicarboxylic acids on normal and malignant melanocytes in culture.
    Hu F; Mah K; Teramura DJ
    Br J Dermatol; 1986 Jan; 114(1):17-26. PubMed ID: 3942687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.